a-Bromo-γ-butyrolactone
CAS: 5061-21-2
Ref. 3D-FB04489
25g | To inquire | ||
50g | To inquire | ||
100g | To inquire | ||
250g | To inquire | ||
500g | To inquire |
Product Information
- 2-Bromo-4-hydroxybutyric acid-gamma-lactone
- (3R)-3-bromodihydrofuran-2(3H)-one
- (3S)-3-bromodihydrofuran-2(3H)-one
- 2(3H)-Furanone, 3-bromodihydro-
- 2-Bromo-4-Butanolide
- 2-Bromo-4-butyrolactone
- 2-Bromo-4-hydroxybutyric acid g-lactone
- 2-Bromo-4-hydroxybutyric acid gamma-lactone
- 2-Bromo-gamma-butyrolactone
- 2-Bromo-γ-butyrolactone
- See more synonyms
- 3-Bromo-2-oxotetrahydrofuran
- 3-Bromo-4,5-dihydro-2(3H)-furanone
- 3-Bromodihydro-2(3H)-furanone
- 3-Bromooxolan-2-one
- 3-Bromotetrahydrofuran-2-one
- 3-bromodihydrofuran-2(3H)-one
- Butyric acid, 2-bromo-4-hydroxy-, γ-lactone
- Butyric acid, α-bromo-γ-hydroxy-, γ-lactone
- NSC 11726
- NSC 56959
- a-Bromo-γ-butyrolatone
- alfa-Bromo-gamma butyrolatone
- Α-Bromo-R-Butyrolactone
- α-Bromo-γ-butyrolactone
- α-Bromobutyric acid γ-lactone
a-Bromo-gamma-butyrolactone (BBAL) is a structural analog of gamma-hydroxybutyric acid, a drug used to treat narcolepsy and cataplexy. BBAL can be synthesized by reacting anhydrous sodium with a mixture of bromoacetic acid and acrylonitrile in the presence of potassium hydroxide. The reaction mechanism for this process is not fully understood but it is believed that a tautomerization may occur between the two possible structures: alpha and beta. This product has been shown to provide pain relief in animal models as well as improve symptoms of metabolic disorders such as diabetes mellitus type II.
Chemical properties
Technical inquiry about: 3D-FB04489 a-Bromo-γ-butyrolactone
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.